THMO Cesca Therapeutics: Rasio Kapitalisasi Pasar marang Nilai Buku

ThermoGenesis Holdings (THMO) - logo korporat

ThermoGenesis relies on California-based plants with strict cGMP controls and stable global distribution free of trade barriers. The price-to-book ratio visualizes this resilience, where the 1.16 level indicates the status of the net asset value assessment parameter. Growth prospects are based on the expansion of CDMO services, the implementation of AI in biobanks, and the demand for CAR-T therapy.

THMO (Cesca Therapeutics) riwayat Kapitalisasi Pasar marang Nilai Buku saka 04.07.2022 nganti 04.08.2024

Rincian metrik keuangan lan pasar ThermoGenesis Holdings, Inc. (THMO)

- rega lan prakiraan konsensus rega:
Bagan rega ThermoGenesis|THMO - Rata-rata rega prakiraan
- data kapitalisasi pasar:
Kapitalisasi pasar ThermoGenesis Holdings Inc.|THMO - Nilai Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham ThermoGenesis|THMO - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku thermogenesis.com|THMO - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal ThermoGenesis|THMO - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas ThermoGenesis Holdings Inc.|THMO - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku ThermoGenesis Holdings Inc.
Pambiji fundamental:ThermoGenesis
Sampel barang ThermoGenesis Holdings Inc.

The price-to-book ratio measures the premium investors place on a company's tangible capital. This multiple compares the market price to the book value of assets. The implementation of BioArchive robotic systems directly impacts asset revaluation, which is reflected in the shift of the price-to-book multiple. This analysis allows for the separation of fundamental growth from market noise, ensuring an objective valuation of ThermoGenesis (THMO) shares.

Pesaing langsung

Rasio Nilai Pasar marang Nilai Buku ABT|thermofisher.com (TMO) - Koefisien Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku GE HealthCare Technologies (GEHC)|Rasio Kapitalisasi marang Nilai Buku Mettler-Toledo|WAT (Waters Corp.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku Bio-Techne Inc. (TECH)|Rasio Kapitalisasi Pasar marang Nilai Buku BRKR (Bruker Corporation)|Rasio Kapitalisasi Pasar marang Nilai Buku azenta.com AZTA|Rasio Kapitalisasi Pasar marang Nilai Buku VREX|SMLR: Rasio Nilai Pasar marang Ekuitas|Rasio Nilai Pasar marang Nilai Buku Butterfly iQ|MLAB (Mesa Laboratories Corp.) - Rasio Kapitalisasi marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku QSI (Quantum-Si)|Koefisien Nilai Pasar marang Nilai Buku NNOX|QTRX (Quanterix) - Rasio Nilai Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku 908 Devices Inc MASS|Rasio Kapitalisasi marang Aset Bersih CapsoVision (CV)|Multiplikator Kapitalisasi Pasar marang Nilai Buku MaxCyte Inc MXCT|Rasio Kapitalisasi Pasar marang Nilai Buku RPID (Rapid Micro)|SEER - Kapitalisasi Pasar marang Nilai Buku|HYPR (Hyperfine) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih FONAR Corp.|DXR - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku MDAI|Rasio Nilai Pasar marang Nilai Buku VIVS (Organovo)|Rasio Kapitalisasi marang Aset Bersih aclarion.com (ACON)|AKYA: Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku Talis Biomedical Corp. TLIS|T2 Biosystems, Inc (TTOO) - Rasio Kapitalisasi Pasar marang Nilai Buku